|
National Stock Number(NSN): 6505-01-105-0048 (6505011050048, 011050048)
| NIIN: |
01-105-0048 |
Item Name: |
MULTIVITAMIN SOLUTION FOR INJECTION |
INC: |
32581
|
| FSC: |
6505
|
Assignment Date: |
|
CRIT: |
|
IIG: |
32581 |
| ISC: |
5 |
Date Standardized: |
|
HMIC: |
|
DODIC: |
|
| NSC: |
7 |
Cancellation Date: |
Jul-01-1994 |
PMIC: |
A |
FIIG: |
A45100 |
| ESD: |
|
Schedule B: |
|
DEMIL: |
A |
DEMIL INT: |
|
| TIIC: |
1 |
Originator: |
|
ADPEC: |
|
RPDMRC: |
|
| NIIN: |
01-204-9753 |
Item Name: |
|
| FSC: |
6505 |
Replacement Date: |
Jul-01-1994 |
|
INC: |
00000 |
| Part Number |
CAGE |
Company |
Status |
RN CC |
RN VC |
DAC |
RN AAC |
RN FC |
RN SC |
RN JC |
SADC |
HCC |
MSDS |
|
M.V.I.-12 |
03884
|
ARMOUR PHARMACEUTICAL CO DIV OF RORER-POULEC RORER INC |
H |
5 |
1 |
|
|
|
|
|
|
|
|
|
M.V.I.-12 |
04443
|
ATLAS ELEVATOR COMPANY |
H |
5 |
1 |
|
|
|
|
|
|
|
|
|
M.V.I.-12 |
04473
|
ASTRA PHARMACEUTICALS LP |
H |
5 |
1 |
|
|
|
|
|
|
|
|
|
NDC00053-1199-33 |
03884
|
ARMOUR PHARMACEUTICAL CO DIV OF RORER-POULEC RORER INC |
H |
3 |
2 |
|
|
|
|
|
|
|
|
|
NDC00186-1199-31 |
04473
|
ASTRA PHARMACEUTICALS LP |
H |
3 |
2 |
|
|
|
|
|
|
|
|
| MOEC |
SOS |
A A C |
R C |
S L C |
CIIC |
U P Q |
U S C |
Unit Price |
UI |
UICF |
MCD |
Action Date |
C/H |
| DA |
S9M |
L |
Z |
M |
|
1 |
|
$58.18 |
PG |
|
C2201X- |
|
H |
| DF |
JDC |
L |
|
M |
|
1 |
|
$209.54 |
PG |
|
------N |
|
H |
| DN |
JDC |
L |
|
M |
|
1 |
|
$58.18 |
PG |
|
9L----- |
|
H |
| DS |
JDC |
L |
|
M |
|
1 |
|
$58.18 |
PG |
|
------- |
|
H |
| MOEC |
PC |
Phrase |
QPA |
UOM |
OOU |
JTC |
| DA |
R |
NOT DMSB STZD |
|
|
|
|
| DF |
R |
NON-STD NON-DMSB REV |
|
|
|
|
| DN |
R |
NON-STD NON-DMSB REV |
|
|
|
|
| DS |
R |
NON-STD NON-DMSB REV |
|
|
|
|
Technical Characteristics Information
| MRC |
Requirement Statement |
Reply Statement |
| AKJA |
ACTIVE MEDICAMENT MEDICINAL STRENGTH |
100.000 MILLIGRAMS ASCORBIC ACID ACTIVE INGREDIENT AND 60.000 MICROGRAMS BIOTIN ACTIVE INGREDIENT AND 400.000 MICROGRAMS FOLIC ACID ACTIVE INGREDIENT AND 40.000 MILLIGRAMS NIACINAMIDE ACTIVE INGREDIENT AND 15.000 MILLIGRAMS PANTOTHENIC ACID ACTIVE INGREDIENT AND 4.000 MILLIGRAMS PYRIDOXINE HYDROCHLORIDE ACTIVE INGREDIENT AND 3.600 MILLIGRAMS RIBOFLAVIN ACTIVE INGREDIENT AND 3.000 MILLIGRAMS THIAMINE ACTIVE INGREDIENT AND 3300.000 INTERNATIONAL UNITS VITAMIN A ACTIVE INGREDIENT AND 5.000 MICROGRAMS VITAMIN B12 ACTIVE INGREDIENT AND 200.000 INTERNATIONAL UNITS VITAMIN D ACTIVE INGREDIENT AND 10.000 INTERNATIONAL UNITS VITAMIN E ACTIVE INGREDIENT |
| CQCT |
PRIMARY CONTAINER TYPE |
BOTTLE |
| CQGK |
SECONDARY CONTAINER TYPE |
PACKET |
| CRLK |
PRIMARY CONTAINER CONTENT QUANTITY |
5.000 MILLILITERS |
| CRXL |
PRIMARY CONTAINER QUANTITY PER SECONDARY CONTAINER |
2 BOTTLE |
| CSCW |
TOTAL PRIMARY CONTAINER QUANTITY |
2 |
| CSCX |
TOTAL SECONDARY CONTAINER QUANTITY |
100 |
| CSGS |
ADMINISTRATION |
INTRAVENOUS |
| FEAT |
SPECIAL FEATURES |
ASCORBIC ACID,VITAMIN A,VITAMIN D,THIAMINE,RIBOFLAVIN,PYRIDOXINE HYDROCHLORIDE,NIACINAMIDE,PANTOTHENIC ACID,AND VITAMIN E CONTAINED IN FIRST 5 ML. VIAL;BIOTIN,FOLIC ACID,AND VITAMIN B12 CONTAINED IN SECOND VIAL;BOTH VIALS TO BE MIXED INTO 500 TO 1000 ML. OF INFUSION SOLUTION |
| PKTY |
UNIT PACKAGE TYPE |
BOX |
| SUPP |
SUPPLEMENTARY FEATURES |
MEDSEP ITEM FOR DOD,ARMOUR PHARMACEUTICAL CO |
| MOE Rule |
Former MOER |
Effective |
AMC |
AMSC |
IMC |
IMCA |
Collaborators |
Receivers |
| A111 |
|
|
3 |
H |
|
|
|
|
| FSKX |
|
|
3 |
H |
|
|
|
|
| N9LM |
|
|
3 |
H |
|
|
|
|
| V540 |
|
|
0 |
0 |
|
|
54 |
54 |
|